Yahoo Finance Modine Manufacturing, IBD Stock Of The Day, Flashes Buy Signal As Cool AI Play
Modine Manufacturing offered investors early entries Monday as AI data center demand is fueling HVAC plays.
Modine Manufacturing offered investors early entries Monday as AI data center demand is fueling HVAC plays.
Wall Street is starting the holiday-shortened week in a muted mood as the wait for the Fed's favorite inflation data begins.
Agios agreed Tuesday to sell its 15% royalty in a brain cancer drug for $905 million upfront. Agios stock broke out at the open.
Vincent Goodwill is joined by the Director of Sports Journalism at Northwestern University J.A. Adande to react to the Eastern and Western Conference Finals games from the weekend and to remember NBA legend Bill Walton.
CAMBRIDGE, Mass., May 28, 2024 (GLOBE NEWSWIRE) -- CarGurus, Inc. (Nasdaq: CARG), the No. 1 visited digital auto platform for shopping, buying, and selling new and used vehicles1, today announced that Jason Trevisan, Chief Executive Officer, is scheduled to participate in a fireside chat at William Blair’s 44th Annual Growth Stock Conference on Tuesday, June 4, 2024 at 2:20 PM ET. A webcast of the fireside chat will be accessible from the Investor Relations page of the company’s website at https
LEXINGTON, Mass., May 28, 2024 (GLOBE NEWSWIRE) -- Keros Therapeutics, Inc. (“Keros” or the “Company”) (Nasdaq: KROS), a clinical-stage biopharmaceutical company focused on developing and commercializing novel therapeutics to treat a wide range of patients with disorders that are linked to dysfunctional signaling of the transforming growth factor-beta (“TGF-ß”) family of proteins, today announced that it appointed Jean-Jacques Bienaimé to its Board of Directors, effective June 1, 2024. “On behal
CHANDLER, Ariz., May 28, 2024 (GLOBE NEWSWIRE) -- (NASDAQ: MCHP) – Microchip Technology Incorporated, a leading provider of smart, connected, and secure embedded control solutions, today announced its intention to offer, subject to market conditions and other factors, $1.1 billion aggregate principal amount of Convertible Senior Notes due 2030 (the “notes”) in a private offering (the “offering”) only to persons reasonably believed to be qualified institutional buyers pursuant to Rule 144A under
CHANDLER, Ariz., May 28, 2024--Insight Enterprises, Inc. (Nasdaq: NSIT) (the "Company") today announced that it is scheduled to participate in the following upcoming investor conference:
UTRECHT, The Netherlands and CAMBRIDGE, Mass., May 28, 2024 (GLOBE NEWSWIRE) -- Merus N.V. (Nasdaq: MRUS) (“Merus”, the “Company,” “we” and “our”), a clinical-stage oncology company developing innovative, full-length multispecific antibodies (Biclonics® and Triclonics®), today announced the launch of a proposed underwritten public offering of $300,000,000 of its common shares (the “Offer Shares”). All of the common shares are being offered by Merus. In addition, Merus expects to grant the underw
SOUTH SAN FRANCISCO, Calif and SALT LAKE CITY, May 28, 2024 (GLOBE NEWSWIRE) -- Standard BioTools Inc. (Nasdaq:LAB) today announced that it has purchased the LSAXT system from Carterra®, a leading provider of high-throughput large and small molecule screening and characterization solutions. This instrument will enable Standard BioTools™ to further validate its SomaScan® Platform by measuring the kinetic properties of SOMAmer® Reagents and deliver precise information about protein binding and bio
RICHMOND, Va., May 28, 2024--Owens & Minor, Inc. (NYSE: OMI), a global healthcare solutions company that provides healthcare products for home-based care, self-manufactured products, proprietary product portfolio, distribution services and innovative technology, announced today that Ed Pesicka, the Company’s President and Chief Executive Officer and Alex Bruni, the Company’s Executive Vice President and Chief Financial Officer, will participate in a webcasted fireside chat at 11:00 a.m. Eastern
VANCOUVER, British Columbia, May 28, 2024--EverGen Infrastructure Corp. ("EverGen" or the "Company") (TSXV: EVGN) (OTCQX: EVGIF), today reported financial results as at and for Q1 2024. All amounts are in Canadian dollars unless otherwise stated and have been prepared in accordance with IFRS Accounting Standards.
SOUTH SAN FRANCISCO, Calif., May 28, 2024 (GLOBE NEWSWIRE) -- Cytokinetics, Incorporated (Nasdaq: CYTK) today announced the closing of its previously announced underwritten public offering of 9,803,922 shares of its common stock at a price to the public of $51.00 per share. The gross proceeds to Cytokinetics from the offering, before offering expenses payable by Cytokinetics, were approximately $500 million. J.P. Morgan, Goldman Sachs & Co. LLC and Morgan Stanley acted as joint book-running mana
The global business broker services market is anticipated to grow from USD 4.92 billion to USD 8.34 billion in 10 years. Offering educational resources, such as webinars, seminars, and industry publications, positions brokers as thought leaders and trusted advisors. Brokers can attract clients and build long-term relationships by sharing expertise and insights on business transitions, market trends, and best practices.Newark, May 28, 2024 (GLOBE NEWSWIRE) -- The Brainy Insights estimates that th
Los Angeles, May 28, 2024 (GLOBE NEWSWIRE) -- After a month-long jury trial in Los Angeles, Hunton Andrews Kurth’s National Trial Team secured a clean-sweep victory and $16.3 million verdict for long-time client Spotlight Ticket Management, Inc. on its claims against StubHub, Inc. for breach of contract and tortious interference with contract and prospective economic advantage. Spotlight, a Calabasas, California-based software company that provides a state-of-the-art ticket management platform t
LIMASSOL, Cyprus, May 28, 2024 (GLOBE NEWSWIRE) -- GDEV Inc. (NASDAQ: GDEV), an international gaming and entertainment company (“GDEV” or the “Company”) released its preliminary unaudited financial and operational results for the first quarter ended March 31, 2024. Financial highlights: First quarter 2024: Revenue of $107 million decreased by 10% year-over-year.Bookings of $109 million increased by 4% year-over-year.Loss for the period of $1 million in Q1 2024 vs. loss of $8 million in Q1 2023.A
Stockholder Vote AGAINST Three Long-Tenured Directors is a Referendum on the Company Running a Strategic Review Process to Maximize Stockholder Value Visit www.UnlockWT.com to View ETFS Capital’s Supplemental Presentation and Other Important Materials NEW YORK, May 28, 2024 (GLOBE NEWSWIRE) -- ETFS Capital Limited (“ETFS Capital”), the largest combined owner of common stock, $0.01 par value (the “Common Stock”), and Series A Non-Voting Convertible Preferred Stock (the “Series A Preferred Stock”)
London, UK, May 28, 2024 (GLOBE NEWSWIRE) -- As Ethereum (ETH) approaches the crucial $4,000 mark, ValueZone, a pioneering cryptocurrency trading platform, is strategically enhancing its services in anticipation of Ethereum's potential surge to new all-time highs. This significant uptrend coincides with growing institutional interest, especially with the impending launch of Ethereum spot ETFs, signaling a robust future for the second-largest cryptocurrency. Ethereum's Bullish Market Trajectory:
Comes as Angela Rayner hit back at ‘desperate’ Tories over row about her former council house living arrangements
The temporary pier built off the coast of Gaza by the US military to transport aid into the war-torn region has broken apart. Heavy seas damaged the pier on Tuesday and sections need “rebuilding and repairing,” a Pentagon spokesperson said. The pier will be moved to Ashdod, a port in Israel, where repairs will be carried out over the course of more than a week.
MANHASSET, N.Y., May 28, 2024--Northwell Health and The Feinstein Institutes for Medical Research physicians have been recognized with Conquer Cancer awards by the American Society of Clinical Oncology (ASCO) Foundation. Stephanie Boisclair, MD, Daniel King, MD, PhD, and incoming Northwell physician-researcher Nicholas Hornstein, MD, PhD, will be recognized during the ASCO Annual Meeting in Chicago, IL (May 31 – June 4).